-0.36%
-2.90%
4.75%
0.01%
-8.16%
41.83%
41.83%
AI Spotlight on GEHC
Create a Free account
Company Description
GE HealthCare Technologies Inc.engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products.The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products.The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products.
The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry.The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan.The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Market Data
| Last Price | 85.1 |
| Change Percentage | -0.36% |
| Open | 85.51 |
| Previous Close | 85.41 |
| Market Cap ( Millions) | 38916 |
| Volume | 322353 |
| Year High | 94.8 |
| Year Low | 74.51 |
| M A 50 | 86.15 |
| M A 200 | 84.18 |
Financial Ratios
| FCF Yield | 3.98% |
| Dividend Yield | 0.18% |
| ROE | 24.93% |
| Debt / Equity | 17.78% |
| Net Debt / EBIDTA | -37.36% |
| Price To Book | 4.6 |
| Price Earnings Ratio | 19.51 |
| Price To FCF | 25.11 |
| Price To sales | 1.98 |
| EV / EBITDA | 10.22 |
News
- Mar -03 - GEHC Stock May Rise on Freelium Magnet Launch, Boosts MR Access
- Feb -27 - GE HealthCare names new president and CEO, China
- Feb -17 - Enlitic and GE HealthCare to Collaborate to Redefine Imaging Data Migration and Cloud Solutions for Enterprise Imaging
- Feb -13 - Why Is GE HealthCare Stock Trading Soaring On Thursday?
- Feb -13 - GE HealthCare Technologies Inc. (GEHC) Q4 2024 Earnings Call Transcript
- Feb -13 - GE HealthCare Q4 Earnings Beat Estimates, Sales Miss, Net Margin Rises
- Feb -13 - GE HealthCare Tops Q4 EPS Forecasts
- Feb -13 - GE HealthCare Technologies (GEHC) Surpasses Q4 Earnings Estimates
- Feb -13 - GE HealthCare forecasts upbeat 2025 profit on steady medical device demand
- Feb -13 - GE HealthCare Posts Q4 Profit Above Expectations
- Feb -13 - GE Healthcare's business grows with boost from imaging and diagnostic drug units
- Feb -13 - GE HealthCare Stock Rises on Strong Earnings and Outlook
- Feb -13 - GE HealthCare reports fourth quarter and full year 2024 financial results
- Feb -10 - GEHC Q4 Earnings: Will Robust Procedures Help Offset Chinese Weakness?
- Feb -10 - PAHC vs. GEHC: Which Stock Is the Better Value Option?
- Feb -10 - What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q4 Earnings
- Feb -04 - GEHC Stock May Rise With $138M Investment in Cork Facility Expansion
- Feb -03 - GEHC Stock May Gain on FDA's Nod for the Updated Voluson Expert Series
- Feb -03 - GE HealthCare Technologies: Still A Solid Long-Term Play
- Jan -31 - GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Imaging
Expected Growth : 5.8 %
What the company do ?
Imaging from GE HealthCare Technologies Inc. provides medical imaging solutions, including MRI, CT, and X-ray machines, to help diagnose and treat diseases.
Why we expect these perspectives ?
GE HealthCare Technologies Inc.'s Imaging segment growth of 5.8% is driven by increasing demand for diagnostic imaging, advancements in AI and digital technologies, and growing adoption of precision medicine. Additionally, an aging population and rising healthcare expenditure in emerging markets contribute to the segment's growth.
Segment n°2 -> Ultrasound
Expected Growth : 5.5 %
What the company do ?
The Ultrasound from GE HealthCare Technologies Inc. is a non-invasive medical imaging technology that uses high-frequency sound waves to produce images of internal organs and tissues.
Why we expect these perspectives ?
GE HealthCare Technologies Inc.'s Ultrasound segment growth of 5.5% is driven by increasing demand for non-invasive diagnostic imaging, advancements in AI-powered ultrasound technology, and growing adoption in emerging markets. Additionally, the rising incidence of chronic diseases, such as cardiovascular and cancer, is fueling demand for ultrasound-based diagnostic procedures.
Segment n°3 -> Patient Care Solutions
Expected Growth : 6.2 %
What the company do ?
Patient Care Solutions from GE HealthCare Technologies Inc. provides healthcare professionals with data-driven insights and tools to improve patient care, streamline clinical workflows, and enhance operational efficiency.
Why we expect these perspectives ?
GE HealthCare's Patient Care Solutions segment growth of 6.2% is driven by increasing demand for healthcare technology, aging population, and rising healthcare expenditure. Additionally, the segment benefits from GE's strong brand reputation, innovative product portfolio, and strategic partnerships. Furthermore, the growing need for efficient patient care and cost reduction in healthcare systems also contributes to the segment's growth.
Segment n°4 -> Pharmaceutical Diagnostics
Expected Growth : 5.9 %
What the company do ?
Pharmaceutical Diagnostics from GE HealthCare Technologies Inc. provides diagnostic products and services for pharmaceutical and biotechnology companies to support drug development and manufacturing.
Why we expect these perspectives ?
The 5.9% growth in Pharmaceutical Diagnostics from GE HealthCare Technologies Inc. is driven by increasing demand for precision medicine, advancements in molecular diagnostics, and growing adoption of point-of-care testing. Additionally, rising healthcare expenditure, aging population, and increasing prevalence of chronic diseases are contributing to the segment's growth.
Segment n°5 -> HealthCare Financial
Expected Growth : 6.1 %
What the company do ?
Healthcare Financials from GE HealthCare Technologies Inc. provides financial management solutions for healthcare organizations to optimize revenue, reduce costs, and improve operational efficiency.
Why we expect these perspectives ?
GE HealthCare Technologies Inc.'s 6.1% growth in HealthCare Financial is driven by increasing demand for digital healthcare solutions, strategic partnerships, and expansion into emerging markets. Additionally, the company's focus on value-based care, population health management, and revenue cycle management are contributing to its growth.
Ge Healthcare Technologies Inc. Products
| Product Range | What is it ? |
|---|---|
| Magnetic Resonance Imaging (MRI) Systems | GE Healthcare's MRI systems provide high-quality images for accurate diagnoses, with advanced features like high-field strength and innovative coil designs. |
| Computed Tomography (CT) Scanners | GE Healthcare's CT scanners offer high-speed, low-dose imaging for precise diagnoses, with advanced features like iterative reconstruction and metal artifact reduction. |
| Ultrasound Systems | GE Healthcare's ultrasound systems provide high-quality images for obstetric, cardiac, and abdominal applications, with advanced features like elastography and contrast-enhanced ultrasound. |
| Patient Monitoring Systems | GE Healthcare's patient monitoring systems provide real-time vital sign monitoring, with advanced features like wireless connectivity and customizable alarm management. |
| Anesthesia Delivery Systems | GE Healthcare's anesthesia delivery systems provide precise control and monitoring of anesthetic gases, with advanced features like automated record-keeping and data analytics. |
| Mammography Systems | GE Healthcare's mammography systems provide high-quality digital breast imaging, with advanced features like 3D tomosynthesis and automated breast ultrasound. |
| Radiation Therapy Systems | GE Healthcare's radiation therapy systems provide precise and effective cancer treatment, with advanced features like stereotactic body radiation therapy and intensity-modulated radiation therapy. |
| Life Care Solutions | GE Healthcare's Life Care Solutions provide a range of healthcare IT solutions, including electronic health records, revenue cycle management, and population health management. |
GE HealthCare Technologies Inc.'s Porter Forces
Threat Of Substitutes
GE HealthCare Technologies Inc. faces moderate threat from substitutes, as there are limited alternatives to its medical imaging and patient care solutions. However, the company's strong brand reputation and customer loyalty mitigate this threat to some extent.
Bargaining Power Of Customers
GE HealthCare Technologies Inc. has a diverse customer base, including hospitals, clinics, and research institutions. While customers have some bargaining power, the company's strong relationships and customized solutions reduce the impact of customer bargaining power.
Bargaining Power Of Suppliers
GE HealthCare Technologies Inc. relies on a network of suppliers for components and materials. While suppliers have some bargaining power, the company's scale and negotiating power mitigate this threat to some extent.
Threat Of New Entrants
The medical technology industry has high barriers to entry, including significant R&D investments and regulatory hurdles. This limits the threat of new entrants and allows GE HealthCare Technologies Inc. to maintain its market position.
Intensity Of Rivalry
The medical technology industry is highly competitive, with several established players competing for market share. GE HealthCare Technologies Inc. faces intense rivalry from companies like Siemens Healthineers, Philips Healthcare, and Canon Medical Systems.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 58.03% |
| Debt Cost | 8.02% |
| Equity Weight | 41.97% |
| Equity Cost | 10.00% |
| WACC | 8.85% |
| Leverage | 138.27% |
GE HealthCare Technologies Inc. : Quality Control
GE HealthCare Technologies Inc. passed 5 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| MTD | Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and … |
| HSTM | HealthStream, Inc. provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including … |
| HQY | HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare … |
| VEEV | Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial … |
| DHR | Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
HealthStream
A-Score
1-Year Total Return ->
🥈
HealthEquity
A-Score
1-Year Total Return ->
🥉
Veeva Systems
A-Score
1-Year Total Return ->
4
Mettler-Toledo
A-Score
1-Year Total Return ->
5
Danaher
A-Score
1-Year Total Return ->
6
